It has been observed that cholesterol and mevalonate are associated with the initiation, progression and aggressiveness of breast cancer risk which are transcriptionally regulated by ERR-α in ER+ and triple negative breast cancer (TNBC) cells [18,19]. This evidence concerns the gene ESRRA and breast cancer.